BON NATURAL LIFE LIMITED (BON) Operating Margin
- Operating margin · 12 months: Value -8.69%; Formula and calculation Operating income / revenue. Period ending 2025-09-30..
Operating margin
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -8.69% | Operating income / revenue. Period ending 2025-09-30. $-1.62M ÷ $18.67M × 100 ≈ -8.69% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -1.62M USD | Operating Income (Loss) |
| Revenue | 18.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 754.19K USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2025-09-30 | $-1.62M | $18.67M | (m) | $754.19K | (m) | -8.69% |
| 2024-09-30 | $1.87M | $23.84M | (m) | $1.62M | (m) | 7.86% |
| 2023-09-30 | $5.92M | $29.52M | (m) | $298.47K | (m) | 20.05% |
| 2022-09-30 | $6.54M | $29.91M | (m) | $424.56K | (m) | 21.87% |
| 2022-03-31 | $5.65M | $27.48M | (m) | $306.73K | (m) | 20.57% |
| 2021-09-30 | $5.40M | $25.49M | (m) | $249.05K | (m) | 21.18% |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $3.47M | $18.22M | (m) | $205.36K | (m) | 19.03% |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $3.18M | $16.40M | (m) | $522.87K | (m) | 19.37% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.